Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 2	2023-11-09		NCT05344209

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Alesund Hospital	40
Haukeland University Hospital	163
Helse Fonna	20
Helse Forde	7
Helse Nord-Trøndelag HF	21
Helse Stavanger HF	67
Oslo University Hospital	327
St. Olavs Hospital	167
University Hospital of North Norway	93
University Hospital, Akershus	87
Vestre Viken Hospital Trust	60

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Vestre Viken Health Trust	Drammen	Norway	3